AAV-mediated overexpression of SAMHD1 exacerbated lipid accumulation through SREBP1/2 activation, while hepatocyte-specific SAMHD1 knockout mice revealed that SAMHD1 deficiency alleviates liver steatosis. Here, SREBF1 is linked to fatty liver disease.